This compound is a protected piperidine carboxylic acid derivative featuring a fluorenylmethoxycarbonyl (Fmoc) group and a tert-butyl ether moiety. It is primarily used as a pharmaceutical intermediate in the synthesis of more complex molecules.
Alcance del contenido: La información de esta página se refiere a la identificación química y a los contextos de suministro industrial, investigación y producción. No constituye una afirmación terapéutica, un consejo médico ni instrucciones de uso de medicamentos.
¿Adquiriendo o suministrando este compuesto?
Publique su inventario o una solicitud de compra
CAS 3020708-19-1
(2S,4R)-4-(tert-butoxy)-1-{[(9H-fluoren-9-yl)methoxy]carbonyl}pyrrolidine-2-carboxylic acid
Fmoc-protected amino acid building block
N-Fmoc-(2S,5S)-5-tert-butoxypipecolicacid
Pharmaceutical intermediate
(2S,5R)-5-tert-butoxy-1-(9H-fluoren-9-ylmethoxycarbonyl)piperidine-2-carboxylic acid
pharmaceutical intermediate for peptide synthesis
3,4-Dichlorobenzoyl chloride
Pharmaceutical intermediate for lamotrigine
(3R,4S)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-1-phenylazetidin-2-one
Impurity standard for ezetimibe
2-N-Boc-Amino-thiazole-5-carboxylic acid
Boc-protected amino acid building block
N-(2-Chloro-6-methylphenyl)-2-[(6-chloro-2-methyl-4-pyrimidinyl)amino]-5-thiazolecarboxamide
Dasatinib intermediate
(2S,4R)-4-tert-butoxy-1-(9H-fluoren-9-ylmethoxycarbonyl)piperidine-2-carboxylic acid
pharmaceutical intermediate
(2S,4S)-1-(9H-fluoren-9-ylmethoxycarbonyl)-4-[(2-methylpropan-2-yl)oxy]piperidine-2-carboxylic acid
CVDIZXJOPDKIAY-AOMKIAJQSA-N
CC(C)(C)O[C@H]1CCN([C@@H](C1)C(=O)O)C(=O)OCC2C3=CC=CC=C3C4=CC=CC=C24
—